Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
On-TIME trial of upfront high-bolus tirofiban before primary angioplasty in acute myocardial infarction
NL-OMON20108Active, not recruiting
- Start
- Apr 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tirofiban in acute ST-segment elevation myocardial infarction (STEMI) (2 arms). Primary endpoint: Residual ST segment deviation at 1 hour. Started Apr 2004; status: active, not recruiting.
02
Drugs
tirofiban
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NL-OMON20108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20108.